{"url_path":"/sec/exoz/10-q/2026/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/2010788/0001493152-26-023035-index.html","accession_number":"0001493152-26-023035","cik":"0002010788","ticker":"EXOZ","issuer_name":"EXOZYMES INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/2010788/0001493152-26-023035-index.html","primary_entity_key":"0002010788","primary_entity_name":"EXOZYMES INC."},"word_count":934,"has_tables":true,"body_markdown":"false\nQ1\n--12-31\n0002010788\nYes\nYes\n\nhttp://fasb.org/us-gaap/2026#UsefulLifeShorterOfTermOfLeaseOrAssetUtilityMember\n\n0002010788\n\n2026-01-01\n2026-03-31\n\n0002010788\n\n2026-05-14\n\n0002010788\n\n2026-03-31\n\n0002010788\n\n2025-12-31\n\n0002010788\n\n2025-01-01\n2025-03-31\n\n0002010788\n\nus-gaap:CommonStockMember\n\n2025-12-31\n\n0002010788\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2025-12-31\n\n0002010788\n\nus-gaap:RetainedEarningsMember\n\n2025-12-31\n\n0002010788\n\nus-gaap:CommonStockMember\n\n2024-12-31\n\n0002010788\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2024-12-31\n\n0002010788\n\nus-gaap:RetainedEarningsMember\n\n2024-12-31\n\n0002010788\n\n2024-12-31\n\n0002010788\n\nus-gaap:CommonStockMember\n\n2026-01-01\n2026-03-31\n\n0002010788\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2026-01-01\n2026-03-31\n\n0002010788\n\nus-gaap:RetainedEarningsMember\n\n2026-01-01\n2026-03-31\n\n0002010788\n\nus-gaap:CommonStockMember\n\n2025-01-01\n2025-03-31\n\n0002010788\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2025-01-01\n2025-03-31\n\n0002010788\n\nus-gaap:RetainedEarningsMember\n\n2025-01-01\n2025-03-31\n\n0002010788\n\nus-gaap:CommonStockMember\n\n2026-03-31\n\n0002010788\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2026-03-31\n\n0002010788\n\nus-gaap:RetainedEarningsMember\n\n2026-03-31\n\n0002010788\n\nus-gaap:CommonStockMember\n\n2025-03-31\n\n0002010788\n\nus-gaap:AdditionalPaidInCapitalMember\n\n2025-03-31\n\n0002010788\n\nus-gaap:RetainedEarningsMember\n\n2025-03-31\n\n0002010788\n\n2025-03-31\n\n0002010788\n\nEXOZ:MDBCapitalHoldingsLLCMember\nsrt:MinimumMember\n\n2026-03-31\n\n0002010788\n\nEXOZ:DepartmentOfEnergyMember\n\n2026-01-01\n2026-03-31\n\n0002010788\n\nEXOZ:NIHMember\n\n2026-01-01\n2026-03-31\n\n0002010788\n\n2025-07-01\n\n0002010788\n\nus-gaap:GrantMember\n\n2026-01-01\n2026-03-31\n\n0002010788\n\nus-gaap:GrantMember\n\n2025-01-01\n2025-03-31\n\n0002010788\n\nus-gaap:PatentsMember\n\n2026-01-01\n2026-03-31\n\n0002010788\n\nus-gaap:PatentsMember\n\n2025-01-01\n2025-03-31\n\n0002010788\n\nEXOZ:MDBCapitalHoldingsLLCMember\n\n2026-03-31\n\n0002010788\n\nEXOZ:MDBCapitalHoldingsLLCMember\n\n2025-12-31\n\n0002010788\n\nus-gaap:FairValueInputsLevel1Member\nus-gaap:CashAndCashEquivalentsMember\n\n2026-03-31\n\n0002010788\n\nus-gaap:FairValueInputsLevel2Member\nus-gaap:CashAndCashEquivalentsMember\n\n2026-03-31\n\n0002010788\n\nus-gaap:FairValueInputsLevel3Member\nus-gaap:CashAndCashEquivalentsMember\n\n2026-03-31\n\n0002010788\n\nus-gaap:CashAndCashEquivalentsMember\n\n2026-03-31\n\n0002010788\n\nus-gaap:FairValueInputsLevel1Member\n\n2026-03-31\n\n0002010788\n\nus-gaap:FairValueInputsLevel2Member\n\n2026-03-31\n\n0002010788\n\nus-gaap:FairValueInputsLevel3Member\n\n2026-03-31\n\n0002010788\n\nus-gaap:FairValueInputsLevel1Member\nus-gaap:CashAndCashEquivalentsMember\n\n2025-12-31\n\n0002010788\n\nus-gaap:FairValueInputsLevel2Member\nus-gaap:CashAndCashEquivalentsMember\n\n2025-12-31\n\n0002010788\n\nus-gaap:FairValueInputsLevel3Member\nus-gaap:CashAndCashEquivalentsMember\n\n2025-12-31\n\n0002010788\n\nus-gaap:CashAndCashEquivalentsMember\n\n2025-12-31\n\n0002010788\n\nus-gaap:FairValueInputsLevel1Member\n\n2025-12-31\n\n0002010788\n\nus-gaap:FairValueInputsLevel2Member\n\n2025-12-31\n\n0002010788\n\nus-gaap:FairValueInputsLevel3Member\n\n2025-12-31\n\n0002010788\n\nEXOZ:LaboratoryEquipmentMember\n\n2026-03-31\n\n0002010788\n\nus-gaap:FurnitureAndFixturesMember\n\n2026-03-31\n\n0002010788\n\nus-gaap:LeaseholdImprovementsMember\n\n2026-03-31\n\n0002010788\n\nEXOZ:LaboratoryEquipmentMember\n\n2025-12-31\n\n0002010788\n\nus-gaap:FurnitureAndFixturesMember\n\n2025-12-31\n\n0002010788\n\nus-gaap:LeaseholdImprovementsMember\n\n2025-12-31\n\n0002010788\n\nEXOZ:SubscriptionAgreementMember\nus-gaap:CommonStockMember\n\n2022-04-01\n2022-04-30\n\n0002010788\n\nEXOZ:SubscriptionAgreementMember\nus-gaap:CommonStockMember\n\n2022-04-30\n\n0002010788\n\nEXOZ:SubscriptionAgreementMember\nEXOZ:FundingWarrantMember\n\n2022-04-30\n\n0002010788\n\nEXOZ:SubscriptionAgreementMember\nEXOZ:FundingWarrantMember\n\n2026-01-01\n2026-03-31\n\n0002010788\n\nEXOZ:SubscriptionAgreementMember\nEXOZ:FundingWarrantMember\n\n2025-01-01\n2025-12-31\n\n0002010788\n\nEXOZ:SubscriptionAgreementMember\nEXOZ:FundingWarrantMember\n\n2026-03-31\n\n0002010788\n\nus-gaap:InvestorMember\n\n2024-11-30\n\n0002010788\n\nEXOZ:PrivateWarrantMember\n\n2024-11-30\n\n0002010788\n\nus-gaap:InvestorMember\n\n2024-11-01\n2024-11-30\n\n0002010788\n\nsrt:MaximumMember\n\n2024-11-01\n2024-11-30\n\n0002010788\n\nEXOZ:UnderwritersMember\n\n2024-11-30\n\n0002010788\n\n2025-01-01\n2025-12-31\n\n0002010788\n\nEXOZ:TwoThousandTwentyPlanMember\n\n2026-03-31\n\n0002010788\n\nEXOZ:TwoThousandTwentyPlanMember\n\n2023-05-01\n\n0002010788\n\nEXOZ:TwoThousandTwentyFiveEquityIncentivePlanMember\n\n2025-07-25\n\n0002010788\n\nEXOZ:OptionHolderMember\n\n2025-11-15\n2025-11-15\n\n0002010788\n\nEXOZ:OptionHolderMember\n\n2026-01-01\n2026-03-31\n\n0002010788\n\nEXOZ:OptionHolderMember\nEXOZ:ExercisePriceOneMember\n\n2026-01-01\n2026-03-31\n\n0002010788\n\nEXOZ:OptionHolderMember\nEXOZ:ExercisePriceTwoMember\n\n2026-01-01\n2026-03-31\n\n0002010788\n\nus-gaap:RestrictedStockUnitsRSUMember\n\n2021-07-19\n2021-07-19\n\n0002010788\n\nus-gaap:RestrictedStockUnitsRSUMember\n\n2021-07-19\n\n0002010788\n\nus-gaap:RestrictedStockUnitsRSUMember\n\n2022-03-27\n2022-03-28\n\n0002010788\n\nus-gaap:RestrictedStockUnitsRSUMember\n\n2022-03-28\n\n0002010788\n\nus-gaap:RestrictedStockUnitsRSUMember\n\n2023-05-01\n2023-05-01\n\n0002010788\n\nus-gaap:RestrictedStockUnitsRSUMember\n\n2023-05-01\n\n0002010788\n\nus-gaap:RestrictedStockUnitsRSUMember\n\n2025-07-01\n2025-07-01\n\n0002010788\n\nus-gaap:RestrictedStockUnitsRSUMember\nEXOZ:LockUpAgreementMember\n\n2025-11-14\n\n0002010788\n\nus-gaap:RestrictedStockUnitsRSUMember\nEXOZ:LockUpAgreementMember\n\n2025-11-14\n2025-11-14\n\n0002010788\n\nus-gaap:RestrictedStockUnitsRSUMember\n\n2025-11-14\n2025-11-14\n\n0002010788\n\n2025-07-01\n2025-07-01\n\n0002010788\n\n2025-07-30\n2025-07-30\n\n0002010788\n\n2025-07-30\n\n0002010788\n\n2025-10-30\n2025-10-30\n\n0002010788\n\n2025-10-30\n\n0002010788\n\n2026-01-14\n2026-01-14\n\n0002010788\n\n2026-01-14\n\n0002010788\n\nus-gaap:EmployeeStockOptionMember\n\n2025-12-31\n\n0002010788\n\nus-gaap:EmployeeStockOptionMember\n\n2025-01-01\n2025-12-31\n\n0002010788\n\nus-gaap:EmployeeStockOptionMember\n\n2026-01-01\n2026-03-31\n\n0002010788\n\nus-gaap:EmployeeStockOptionMember\n\n2026-03-31\n\n0002010788\n\nus-gaap:EmployeeStockOptionMember\n\n2025-03-31\n\n0002010788\n\nus-gaap:EmployeeStockOptionMember\n\n2025-01-01\n2025-03-31\n\n0002010788\n\nus-gaap:RestrictedStockUnitsRSUMember\n\n2025-12-31\n\n0002010788\n\nus-gaap:RestrictedStockUnitsRSUMember\n\n2025-01-01\n2025-12-31\n\n0002010788\n\nus-gaap:RestrictedStockUnitsRSUMember\n\n2026-01-01\n2026-03-31\n\n0002010788\n\nus-gaap:RestrictedStockUnitsRSUMember\n\n2026-03-31\n\n0002010788\n\nus-gaap:RestrictedStockUnitsRSUMember\n\n2025-03-31\n\n0002010788\n\nus-gaap:RestrictedStockUnitsRSUMember\n\n2025-01-01\n2025-03-31\n\n0002010788\n\nus-gaap:WarrantMember\n\n2026-01-01\n2026-03-31\n\n0002010788\n\nus-gaap:WarrantMember\n\n2025-01-01\n2025-03-31\n\n0002010788\n\nus-gaap:EmployeeStockOptionMember\n\n2026-01-01\n2026-03-31\n\n0002010788\n\nus-gaap:EmployeeStockOptionMember\n\n2025-01-01\n2025-03-31\n\n0002010788\n\nus-gaap:RestrictedStockUnitsRSUMember\n\n2026-01-01\n2026-03-31\n\n0002010788\n\nus-gaap:RestrictedStockUnitsRSUMember\n\n2025-01-01\n2025-03-31\n\n0002010788\n\nEXOZ:LicensedProductMember\nEXOZ:LicenseAgreementMember\n\n2026-01-01\n2026-03-31\n\n0002010788\n\nEXOZ:SecondLicensedProductMember\nEXOZ:LicenseAgreementMember\n\n2026-01-01\n2026-03-31\n\n0002010788\n\nEXOZ:LicenseAgreementMember\n\n2026-01-01\n2026-03-31\n\n0002010788\n\nEXOZ:LicenseAgreementMember\nus-gaap:CommonStockMember\n\n2026-01-01\n2026-03-31\n\n0002010788\n\nEXOZ:LicenseAgreementMember\n\n2025-01-01\n2025-03-31\n\n0002010788\n\n2023-04-03\n2023-04-03\n\n0002010788\n\nEXOZ:LeaseAgreementMember\n\n2023-04-01\n2023-04-30\n\n0002010788\n\n2023-10-30\n2023-10-30\n\n0002010788\n\n2023-10-30\n\n0002010788\n\n2025-10-01\n2025-12-31\n\n0002010788\n\nus-gaap:SubsequentEventMember\nEXOZ:PublicVentureLLCMember\n\n2026-04-10\n2026-04-10\n\niso4217:USD\n\nxbrli:shares\n\niso4217:USD\n\nxbrli:shares\n\nxbrli:pure\n\nEXOZ:Segment\n\n \n\n \n\n \n\n**UNITED\nSTATES**\n\n**SECURITIES\nAND EXCHANGE COMMISSION**\n\n**Washington,\nD.C. 20549**\n\n \n\n**FORM\n10-Q**\n\n \n\n☒\n**QUARTERLY\nREPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\n \n\n**FOR\nTHE QUARTERLY PERIOD ENDED MARCH 31, 2026**\n\n \n\n**OR**\n\n \n\n☐\n**TRANSITION\nREPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\n \n\nCommission\nFile Number: **001-42204**\n\n \n\n**EXOZYMES\nINC.**\n\n(Exact\nname of registrant as specified in its charter)\n\n \n\n**Nevada**\n \n**83-4550057**\n\n(State\nor other jurisdiction of\n\nincorporation\nor organization)\n\n \n\n(I.R.S.\nEmployer\n\nIdentification\nNo.)\n\n \n \n \n\n**750\nRoyal Oaks Drive, Suite 106**\n\n**Monrovia,\nCA 91016**\n\n \n**91016**\n\n(Address of principal executive\noffices)\n \n(Zip code)\n\n \n\n**(626)\n415-1488**\n\n(Registrant’s\ntelephone number, including area code)\n\n \n\nSecurities\nregistered pursuant to Section 12(b) of the Exchange Act: None\n\n \n\n**Title\nof each class**\n \n**Trading\nSymbol(s)**\n \n**Name\nof each exchange on which registered**\n\nCommon Stock, $.000001\n \nEXOZ\n \nNasdaq Capital Markets\n\n \n\nSecurities\nregistered pursuant to Section 12(g) of the Act: None\n\n \n\nIndicate\nby check mark whether the issuer (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the\npreceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such\nfiling requirements for the last 90 days. **YES ☒ NO ☐**\n\n \n\nIndicate\nby check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule\n405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant\nwas required to submit such files). **YES ☒ NO ☐**\n\n \n\nIndicate\nby check mark whether the registrant is a large, accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting\ncompany, or an emerging growth company. See the definitions of “large, accelerated filer,” “accelerated filer,”\n“non-accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2\nof the Exchange Act.\n\n \n\n**Large Accelerated\nFiler**\n**☐**\n**Accelerated\nFiler**\n**☐**\n\n**Non-accelerated Filer**\n**☐**\n**Smaller Reporting Company**\n**☒**\n\n \n \n**Emerging Growth Company**\n**☒**\n\n \n\nIf\nan emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying\nwith any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒\n\n \n\nIndicate\nby check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). **YES ☐ NO ☒**\n\n \n\nAs\nof May 14, 2026, the number of outstanding shares of Common Stock was 8,478,992.\n\n \n\n \n\n \n\n \n\n \n\n \n\n**TABLE\nOF CONTENTS**\n\n \n\n \n \n \n\n**Page**\n\n**Number**\n\nPART\nI\n[FINANCIAL INFORMATION](#sa_001)\n \n3\n\n \n \n \n \n\n[Item 1 - Condensed Unaudited Consolidated Financial Statements](#sa_007)\n \n3\n\n \n \n \n\n[Condensed Unaudited Consolidated Balance Sheets – March 31, 2026, and December 31, 2025](#sa_002)\n \n3\n\n \n \n \n\n[Condensed Unaudited Consolidated Statements of Operations – Three months ended March 31, 2026, and 2025](#sa_003)\n \n4\n\n \n \n \n\n[Condensed Unaudited Consolidated Statements of Changes in Equity – Three months ended March 31, 2026, and 2025](#sa_004)\n \n5\n\n \n \n \n\n[Condensed Unaudited Consolidated Statements of Cash Flows – Three months ended March 31, 2026, and 2025](#sa_005)\n \n6\n\n \n \n \n\n[Notes to Condensed Unaudited Consolidated Financial Statements](#sa_006)\n \n7"}